Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (22)
- Safety monitoring and information (13)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Legislation (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
Collection content
114 result(s) found, displaying 81 to 90
-
User guideHow to search TGA business services for approved ingredients and accepted TGA terminology.
-
User guideThis document replaces AU eCTD specification - Module 1 and regional information Version 3.0 and contains updated information.
-
FormsSponsors can use this form to apply for an additional trade name for a registered prescription medicine, under section 23 of the Therapeutic Goods Act 1989.
-
FormsUse this form for Category 1 and Comparable Overseas Regulator (COR) report-based prescription medicines applications, or variations.
-
FormsFind out what process to follow if a product is manufactured using a human embryo or a human embryonic stem cell, or any material sourced from such an embryo or stem cell.
-
FormsThe Pre-submission Planning Form (PPF) provides the TGA with the necessary information on the scope and scale of application to arrange appropriate resourcing for the processing and evaluation of an application.
-
FormsApplication form to import, supply or export a therapeutic good that does not comply with standards.
-
FormsFind out how the free trade agreement affects your application to include a product on the Australian Register of Therapeutic Goods.
-
User guideFind out when you should use a literature-based submissions (LBS) for your application.
-
User guideUser guide on how to submit shortage/discontinuation notifications to the TGA